If the PEAs are released as planned by September and they show clear benefits in going ahead with Renard and also a profitable operation even at current spod prices then I think there's every chance we'll see a meaningful increase in our SP. Such a scenario will also virtually guarantee that the Renard option will be taken up, even if it's not until next February. In the meantime anything other than absolutely stellar assays are not likely to stir too much buying interest.
If the PEAs are released as planned by September and they show...
-
- There are more pages in this discussion • 412 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add WR1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.5¢ |
Change
-0.025(3.73%) |
Mkt cap ! $140.6M | |||
| Open | High | Low | Value | Volume |
| 66.0¢ | 66.5¢ | 64.0¢ | $464.1K | 711.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 26507 | 64.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 5738 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| WR1 (ASX) Chart |